Rp-HPLC Method for Simultaneous Estimation of Levocetirizine Dihydrochloride and Montelukast Sodium in tablets

  • Mohammed Ishaq Department of Pharmaceutical Analysis, Balaji College of Pharmacy, Anantapur - 515001, A.P. India.
  • Vanitha Prakash K. Department of Pharmaceutical Analysis, SSJ College of Pharmacy, Gandipet, Hyderabad, A.P.
  • Krishna Mohan G. Centre for Pharmaceutical Sciences, IST, JNTU Hyderabad, A.P.
  • Muneer Shaik Department of Pharmaceutical Analysis, Balaji College of Pharmacy, Anantapur, A.P.
  • Hindustan Abdul Ahad Department of Pharmaceutical Analysis, Balaji College of Pharmacy, Anantapur, A.P.
Keywords: levocetirizine dihydrochloride, Montelukast sodium, Waters C18 analytical column

Abstract

A simple, selective and sensitive reverse phase high performance liquid chromatography (Rp-HPLC) method has been proposed for the simultaneous quantitative determination of levocetirizine dihydrochloride (LEV) and Montelukast sodium (MON) in pure form as well as in its pharmaceutical formulation. The chromatography was carried out on Waters C18 analytical column (15cm × 4.6 mm, 5µ) using a mobile phase of methanol: water (75:25 v/v). The flow rate was 1.0 ml/min with detection at 235 nm. The retention time of LEV and MON were found to 2.88 and 3.83 min respectively. The linearity for LEV and MON were in the range of 50-150 µg/mL and 100- 300 µg/mL respectively. The recoveries of LEV and MON were found to be 100.00% and 99.00%, respectively. The proposed method was validated and successfully applied to the estimation of LEV and MON in combined tablet dosage forms.

Downloads

Download data is not yet available.

References

O’Neil, M.J., Merck, 2001. The Merck Index, 13th ed. Merck Research Laboratories.

Devalia JL, De Vos C, Hanotte F, Baltes E. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy. 2001 Jan; 56(1):50-7.

V. Choudhari et al., Simultaneous Determination of Montelukast Sodium and Levocetirizine Dihydrochloride in Pharmaceutical Preparations by Ratio Derivative Spectroscopy, Int.J. PharmTech Res.2010,2(1) pp 04-09.

Singh RM, Saini PK, Mathur SC, Singh GN, Lal B, Development and Validation of a RP-HPLC Method for Estimation of Montelukast Sodium in Bulk and in Tablet Dosage Form, Indian J Pharm Sci, 72(2), 2010, 235-237.

Sharma S et al., Development and Validation of TLC-Densitometry Method for Simultaneous Quantification of Montelukast Sodium and Levocetirizine Dihydrochloride Pharmaceutical Solid dosage form. Der Pharmacia Lettre, 2 (1), 2010, 489-94.

Rathore AS, Sathinarayana L, Mahadik KR, Development of Validated HPLC and HPTLC Methods for Simultaneous Determination of Levocetirizine dihydrochloride and Montelukast sodium in Bulk Drug and Pharmaceutical Dosage Form. Pharma Anal Acta, An Open Access Journal, 1(1) 2010, 1-6.

Sankar ASK et al., Simultaneous Estimation of Montelukast Sodium and Levocetirizine Hydrochloride from Tablet Dosage Form. Res J Phar and Tech, 2(4), 2009, 443-445.

Choudhari V et al., Simultaneous Determination of Montelukast Sodium and Levocetirizine Dihydrochloride in Pharmaceutical Preparations by Ratio Derivative Spectroscopy, Inter J Pharma Tech Res, 2(1), 2010, 4-9.

Ashokkumar S, Senthil Raja M, Perumal P, RP-HPLC Method Development and Validation for Simultaneous Estimation of Montelukast Sodium and Levocetirizine Dihydrochloride, Inter J Pharm Res, 1 (4), 2009, 8-12.

Validation of Analytical Procedures: Methodology (CPMP/ICH/281/95), ICH Harmonized Tripartite Guidelines.

Published
2015-06-30
Issue
Vol 1 No 1 (2015): IEJPS
Section
Original Articles

Copyright (c) 2015 Indian E-Journal of Pharmaceutical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).